Johnson & Johnson: 100 Million Doses Of Vaccine By June For US
The company expects results of its phase 3 trial by next week, and once its vaccine is approved, it would be the third vaccine in the U.S. Sanofi, while awaiting development of its vaccine, says it can help manufacture Pfizer's beginning this summer.